Revvity Expands Alliance with Genomics England

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Revvity Expands Alliance with Genomics England

, MT Newswires - 2:09 PM ET 3/20/2025 default

02:09 PM EDT, 03/20/2025 (MT Newswires) -- Revvity ( RVTY ) said Thursday it has signed a new agreement with Genomics England to further collaborate on the Generation Study, a national initiative to screen up to 100,000 newborns for more than 200 rare genetic disorders.

Under the new contract, Revvity ( RVTY ) said it will also provide DNA sequencing services to help screen newborns for rare genetic conditions, adding to its previous DNA extraction services.

The firm said it will now be able to provide an end-to-end solution with a localized lab facility to advance the screening process.

Price: 107.11, Change: -2.81, Percent Change: -2.56

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.